Physician profile
John Galligan
NPI 1194773689
$12,380.77
in general payments reported to CMS, 2019-2025
21 companies · $463 in 2025
The $463 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,335 · 2020: $852 · 2021: $1,671 · 2022: $5,616 · 2023: $966 · 2024: $480 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,059 · Education: $611 · Travel and Lodging: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,058.86 |
| Education | $610.72 |
| Travel and Lodging | $238.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,381.95 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $2,381.18 | 2022-2025 | A.L.P.S., Persona |
| Titan Surgical Group, LLC | $1,459.96 | 2021 | |
| Stryker Corporation | $1,325.06 | 2021-2025 | Prophecy, Omega, Infinity |
| Conetic Solutions, INC. | $750.31 | 2021-2025 | |
| Musculoskeletal Transplant Foundation INC. | $244.83 | 2023 | |
| Rsw Medical Company, INC. | $232.73 | 2019 | |
| Medtronic, INC. | $146.76 | 2022 | |
| Integra Lifesciences Corporation | $80.88 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $65.53 | 2023-2025 | Physio-Stim, Accelstim |
| Depuy Synthes Sales INC. | $58.92 | 2023-2025 | Monovisc, Orthovisc, Minibunion |
| Treace Medical Concepts, INC. | $58.16 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $30.25 | 2025 | Exparel |
| Amgen INC. | $27.58 | 2022-2025 | Evenity, Prolia |
| Sanara Medtech INC. | $26.21 | 2024 | Celleraterx |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $24.06 | 2025 | |
| Spr Therapeutics, INC | $23.97 | 2022 | |
| Bioventus LLC | $20.71 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.99 | 2022 | |
| Abbvie INC. | $13.31 | 2021 | |
| Smith+Nephew, INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Galligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.